14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.48 $4.41 Friday, 3rd May 2024 EVAX stock ended at $3.95. This is 1.54% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.64% from a day low at $3.85 to a day high of $3.99.
90 days $2.82 $4.74
52 weeks $0.470 $13.55

Historical Evaxion Biotech A/S prices

Date Open High Low Close Volume
Feb 22, 2024 $3.85 $4.05 $3.73 $3.83 46 336
Feb 21, 2024 $4.02 $4.10 $3.76 $3.88 57 024
Feb 20, 2024 $4.42 $4.50 $3.80 $3.99 440 834
Feb 16, 2024 $4.22 $4.26 $4.00 $4.05 48 696
Feb 15, 2024 $4.23 $4.39 $3.93 $4.15 53 499
Feb 14, 2024 $4.09 $4.39 $4.06 $4.21 53 683
Feb 13, 2024 $4.11 $4.38 $3.93 $4.00 76 480
Feb 12, 2024 $4.60 $4.74 $4.02 $4.21 245 829
Feb 09, 2024 $4.30 $4.46 $4.01 $4.02 72 635
Feb 08, 2024 $4.29 $4.54 $3.97 $4.23 67 023
Feb 07, 2024 $4.50 $4.60 $4.27 $4.28 97 823
Feb 06, 2024 $4.43 $4.74 $4.21 $4.50 185 118
Feb 05, 2024 $4.30 $4.56 $4.15 $4.25 97 887
Feb 02, 2024 $4.60 $4.69 $4.18 $4.38 205 261
Feb 01, 2024 $4.01 $5.29 $4.01 $4.60 1 306 771
Jan 31, 2024 $5.37 $5.50 $3.68 $3.93 656 988
Jan 30, 2024 $6.34 $6.39 $5.60 $5.79 140 266
Jan 29, 2024 $7.01 $7.38 $6.36 $6.55 149 843
Jan 26, 2024 $8.41 $9.41 $7.18 $7.38 522 911
Jan 25, 2024 $10.65 $10.69 $8.76 $9.41 2 009 097
Jan 24, 2024 $9.33 $13.55 $8.35 $10.65 31 725 932
Jan 23, 2024 $5.55 $5.57 $4.15 $4.99 807 683
Jan 22, 2024 $6.08 $6.10 $3.36 $3.66 204 214
Jan 19, 2024 $0.740 $0.740 $0.650 $0.670 111 348
Jan 18, 2024 $0.760 $0.84 $0.701 $0.739 92 607
Click to get the best stock tips daily for free!

About Evaxion Biotech A/S

Evaxion Biotech A/S Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various... EVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT